window.datalayer
window.datalayer
||
function
gtag(){datalayer.push(arguments)};gtag("js
new
date());gtag("set
developer_id.dmdhkmt
true);gtag("config
UA-3585337
groups":"default","anonymize_ip":true,"page_placeholder":"placeholder_page_path"});gtag("config
L3KDESR6P8
groups":"default","page_placeholder":"placeholder_page_location"});</script
div#sliding
popup
div#sliding
popup
.eu
cookie
withdraw
banner
.eu
cookie
withdraw
tab
background
0779bf
div#sliding
popup.eu
cookie
withdraw
wrapper
background
transparent
sliding
popup
h1
sliding
popup
h2
sliding
popup
h3
sliding
popup
sliding
popup
label
sliding
popup
div
.eu
cookie
compliance
more
button
.eu
cookie
compliance
secondary
button
.eu
cookie
withdraw
tab
color
ffffff
.eu
cookie
withdraw
tab
border
color
ffffff
.disagree
button.eu
cookie
compliance
more
button
focus
.eu
cookie
compliance
agree
button
focus
.eu
cookie
compliance
default
button
focus
.eu
cookie
compliance
hide
button
focus
.eu
cookie
compliance
more
button
thank
you
focus
.eu
cookie
withdraw
button
focus
.eu
cookie
compliance
save
preferences
button
focus
outline
3px
solid
f00
nih
awards
to
annoviant
to
advance
heart
disease
technology</title
.modern.center
h2
clear
both
important;}.utility
navigation
.navbar
nav
li
margin
important;}@media
min
width
768px
.gt
banner
attachment
.gt
slide
teaser
wrapper
h4
font
size
1rem
important;}}@media
max
width
991.98px
.card
.col-6
flex
max
width
.institute
leadership
.card
body
padding
1.25rem
.institute
leadership
img
width
100%;min
height
unset
@media
min
width
992px
and
max
width:1199.98px
.institute
leadership
img
min
height
unset
.main
container
.banner
wrapper.white
a.btn
secondary
color
inherit
important
text
decoration
none
important;}.banner
wrapper.white
.a.btn.btn
secondary
color
black
important;text
decoration
none
important;}.banner
wrapper.white
a.btn.btn
secondary
hover
color
white
important;text
decoration
none
important;}.frontpage
.events
.views
row
.views
col
first
of
type::before
display
none;}.mercury
margin
bottom
1em
important;}.views
field.views
field
title
.field
content
font
size
1.2rem
important;}.views
field.views
field
title
margin
top
1rem
important;}.news
content
position
static
important;}.fa
twitter::before
content
\e61b
important;}form.gsc
search
box
max
width
600px;}table
.gstl_50
margin
important
skip
to
main
navigation
skip
to
main
content
georgia
tech
search
submit
nih
awards
to
annoviant
to
advance
heart
disease
technology</span
apr
atlanta
nbsp;</strong
annoviant
inc.
health
technology
company
and
member
startup
in
the&nbsp;<a
href="https://medtech.gatech.edu/">center
for
medtech
excellence</a>&nbsp;at
georgia
tech's&nbsp;<a
href="https://innovate.gatech.edu/">enterprise
innovation
institute</a
is
receiving
million
national
institutes
of
health
nih
grant
to
further
scale
the
development
and
commercialization
of
its
txguard
pulmonary
valved
conduit
for
pediatric
heart
disease.</p
the
award
follows
two
phase
nih
grants
the
company
received
the
most
recent
being
in
2021.</p
annoviant
's
patented
txguard
stands
at
the
forefront
of
technological
innovation
in
conduit
replacements
for
treating
congenital
heart
disease
chd
the
most
prevalent
birth
defect
globally
and
leading
cause
of
birth
related
mortality
the
company
said.</p
chd
encompasses
broad
range
of
abnormalities
that
disrupt
blood
flow
to
and
from
the
heart
it
affects
approximately
40,000
newborns
annually
or
of
births
in
the
u.s.
and
million
worldwide
with
an
estimated
million
chd
patients
in
the
u.s.
alone
the
need
for
advanced
solutions
is
paramount.</p
addressing
critical
shortcomings
observed
in
current
commercial
devices
txguard
offers
clinical
advantages
notably
its
resistance
to
calcification
thrombosis
infection
and
the
host
cell
integration
this
cutting
edge
technology
marks
new
era
in
pediatric
cardiac
interventions
providing
durable
pulmonary
valved
grafts
that
adapt
and
regenerate
alongside
patients
minimizing
the
need
for
multiple
re
operations
over
their
lifetimes.</p
the
center
for
medtech
excellence
which
launched
in
works
with
early
stage
life
sciences
startups
that
have
specific
obstacles
that
young
tech
companies
in
other
sectors
do
n't
face.</p
pediatric
patients
with
chd
often
undergo
multiple
cardiovascular
surgeries
throughout
their
lives
with
associated
costs
totaling
billions
for
the
u.s.
healthcare
industry
txguard
offers
transformative
solution
to
this
ongoing
challenge
promising
extended
durability
and
reduced
healthcare
burden
for
patients
and
providers
alike.</p
he
credited
the
company
's
work
with
the
center
for
medtech
excellence
and
being
health
tech
startup
in
the&nbsp;<a
href="https://atdc.org/">advanced
technology
development
center
atdc)</a
the
enterprise
innovation
institute
's
startup
incubator
as
being
pivotal
in
annoviant
's
growth.</p
atdc
sbir
sttr
catalyst
connie
casteel
who
works
with
the
incubator
's
portfolio
companies
to
help
the
prepare
for
these
federal
non
dilutive
funding
grants
had
worked
with
annoviant
on
its
federal
funding
approach
and
strategy.</p
Contact</h4
pralte
c.
paul
peralte@gatech.edu
1210</p
Categories</h4
biotechnology
health
bioengineering
genetics</a
business</a
life
sciences
and
biology</a
research</a
news
room
topics</h4
business
and
economic
development</a
health
and
medicine</a
Keywords</h4
annoviant</a
atdc</a
center
for
medtech
excellence</a
heart
disease</a
pediatrics</a
georgia
manufacturing
extension
partnership</a
go
researchnews</a
georgia
tech
research
institute</a
research
at
georgia
tech</a
georgia
institute
of
Technology</h3
north
avenue
enable
accessibility</a></p></div
georgia
tech
georgia
institute
of
technology</p
